Skip to main content
. Author manuscript; available in PMC: 2016 Mar 16.
Published in final edited form as: Br J Haematol. 2015 Nov 18;172(3):384–391. doi: 10.1111/bjh.13832

Table III.

Response evaluation.

Azacitidine Azacitidine
+Entinostat


N % N %
CR 3 12·5 0 0
PR 1 4·2 0 0
No change/stable 8 33·3 17 73·9
Progression/relapse 4 16·7 2 8·7
Trilineage HI without CR or PR 7 29·2 4 17·4
HI -not trilineage 1 4·2 0 0
Platelet HI 1
Haematological Normalization (CR/PR/trilineage HI) 11 46% 4 17%

CR, complete response; PR, partial response; HI, haematological improvement.

Response was evaluated according to International Working Group 2000 criteria (Cheson et al, 2000).